Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
+51,807
New +$1.36M ﹤0.01% 2049
2026
Q1 		– Sell
-15,986
Closed -$320K – 10210
2025
Q4 		$261K Buy
+15,986
New +$241K ﹤0.01% 3960
2025
Q1 		– Sell
-5,224
Closed -$65.9K – 9727
2024
Q4 		$75K Buy
5,224
+2,055
+65% +$32.4K ﹤0.01% 5458
2024
Q3 		$71K Buy
+3,169
New +$65.5K ﹤0.01% 5557
2024
Q1 		– Sell
-14,200
Closed -$624K – 9931
2023
Q4 		$794K Buy
14,200
+1,468
+12% +$63.9K ﹤0.01% 3244
2023
Q3 		$525K Buy
12,732
+7,637
+150% +$397K ﹤0.01% 3349
2023
Q2 		$284K Buy
+5,095
New +$276K ﹤0.01% 3914
2023
Q1 		– Sell
-1,053
Closed -$49.2K – 10174
2022
Q4 		$38K Sell
1,053
-15,852
-94% -$518K ﹤0.01% 6206
2022
Q3 		$481K Buy
16,905
+12,702
+302% +$484K ﹤0.01% 3517
2022
Q2 		$190K Buy
+4,203
New +$218K ﹤0.01% 4679
2021
Q2 		– Sell
-471
Closed -$85.2K – 10732
2021
Q1 		$85K Buy
+471
New +$81.3K ﹤0.01% 5962
2020
Q2 		– Sell
-157
Closed -$12.2K – 8386
2020
Q1 		$9K Sell
157
-209
-57% -$16.3K ﹤0.01% 6553
2019
Q4 		$27K Buy
+366
New +$22K ﹤0.01% 5741

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading's TXG Position: Q2 2026 in Review

Simplex Trading opened a new position in 10x Genomics (TXG) in Q2 2026: 51,807 shares worth $1.99M. The stake represents ﹤0.01% of the portfolio and ranks #2049 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TXG as recently as Q4 2025.

Simplex Trading first reported a position in TXG in Q4 2019 and has held it in 13 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Simplex Trading held 51,807 shares of 10x Genomics worth $1.99M as of Q2 2026.
  • 10x Genomics was a new Simplex Trading position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2049 holding.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and has held it in 13 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.